^
    2ms
    Pillar Biosciences announces expansion of NGS commercial partnership with Illumina (PRNewswire)
    "Pillar Biosciences...today announced an expansion of their existing partnership with Illumina, through which a broader portfolio of Pillar's oncoReveal™ NGS panels will now be offered directly by Illumina. Several of Pillar's oncology panels will be available as part of the validated libraries on the MiSeq i100 Series sequencing platform, which launched last week."
    Licensing / partnership
    |
    OncoReveal™ BRCA1 & BRCA2 plus CNV Panel • OncoReveal™ Myeloid Panel • oncoReveal™ Core LBx • oncoReveal™ Fusion LBx Panel • oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel • oncoReveal™ Solid Tumor v2 Panel